Feasibility study of extemporaneous control of cytotoxic preparations: Tests with an innovating spectrometer coupling UV/visible and IR detections

EJHP Practice

Volumn 15, Issue 1, 2009, Pages 28-31

  Baumgartner, Pierre ^a   Ripoche, Natacha ^b   Audeval, Christelle ^b   Rochard, Sophie ^b  

^a CENTRE RENÉ GAUDUCHEAU   (France)

^b NONE

Author keywords

Cytotoxic; Quality assurance; Reconstitution unit; Spectrophotometry

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CETUXIMAB; DOXORUBICIN; FLUOROURACIL; PACLITAXEL;

ARTICLE; CALIBRATION; FEASIBILITY STUDY; INFRARED SPECTROSCOPY; PRESCRIPTION; QUANTITATIVE ANALYSIS; RELIABILITY; SAFETY; SPECTROMETER; ULTRAVIOLET SPECTROSCOPY; VALIDATION PROCESS;

EID: 69949130283     PISSN: 17819989     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Astier A. The stability of anticancer drugs. Eur J Hosp Pharm. 2007;13(2):90-92
2. Watt S, Antier D, Jacques V, Grassin J. New program for quality control of cytotoxics manufactured in centralised unit. J Pharm Clin. 2002;21(3):179-182
3. Paci A, Desmaris R, Bourget P. Analytical controls and acceptance sampling plans in a hospital chemotherapy production unit. Eur J Hosp Pharm. 2006;12(4):82-83
4. Larson RR, Khazaeli MB, Dillon HK. Development of an HPLC method for simultaneous analysis of five antineoplastic agents. Appl Occup Environ Hyg. 2003;18(2):109-119
5. Basuyau F, Brunelle P. Comparison of two fast physical measurements for the dose control of cytotoxic injectable preparations before administration. Application to 5-Fluorouracil. J Pharm Clin. 2000;19(1):5-9.
6. Michel C, Mohammad M, Crauste-Manciet S, Brossard D. Faisabilité du dosage systématique des anticancéreux préparés dans une unité de reconstitution. Proceedings of the Congrès Hopipharm; 2004 June 2-4; Dijon, France. Communication résumé Poster 85 [cited 2008 May 28]. Available from: www.synprefh.org/hopipharm/ communications-2004.pdf
7. Mullot JU, Carde A, Galvez O, Edouard B. Infrared spectrophotometry: a versatile analytical tool in hospital pharmacy. Ann Pharm Fr. 2003;6(6):412-417
8. Farhang-Asnafi S, Callaert S, Barre J, et al. Influence of intravenous admixtures on the stability of the new solution of 5-fluorouracil. J Pharm Clin. 1997;16(1):45-48
9. Havard L, Bonan B, Huen JM, et al. Quality control in centralised cytotoxic reconstitution unit: dream or reality? STP Pharma Prat. 2005;15(2):148-160
10. Martin F, Legat C, Coutet J, et al. Prevention of preparation errors of cytotoxic drugs in centralized units: from epidemiology to quality assurance. Bull Cancer. 2004;91(12):972-976